01367nam 2200361Ia 450 991069937670332120230902162243.0(CKB)5470000002402147(OCoLC)500848557(EXLCZ)99547000000240214720100119d2005 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] noncontraceptive estrogen drug products for the treatment of vasomotor symptoms and vulvar and vaginal atrophy symptoms : recommended prescribing information for heatlh care providers and patient labelingRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,[2005]1 online resource (25 pages)"Draft guidance.""Labeling.""Revision 4.""November 2005."Guidance for industry MenopauseHormone therapyLabelingUnited StatesMenopauseHormone therapyLabelingCenter for Drug Evaluation and Research (U.S.)GPOGPOBOOK9910699376703321Guidance for industry3434577UNINA